-
1
-
-
0028858885
-
Inhibition of human acetylcholinesterase by cyclophosphamide
-
Al-Jafari A.A., Duhaiman A.S., Kamal M.A. Inhibition of human acetylcholinesterase by cyclophosphamide. Toxicology. 96:1995;1-6.
-
(1995)
Toxicology
, vol.96
, pp. 1-6
-
-
Al-Jafari, A.A.1
Duhaiman, A.S.2
Kamal, M.A.3
-
2
-
-
0027092277
-
Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase with one of the highest known affinities
-
Hodge A.S., Humphrey D.R., Rosenberry T.L. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase with one of the highest known affinities. Mol. Pharmacol. 41:1992;937-942.
-
(1992)
Mol. Pharmacol.
, vol.41
, pp. 937-942
-
-
Hodge, A.S.1
Humphrey, D.R.2
Rosenberry, T.L.3
-
3
-
-
15644368835
-
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease
-
Smith C.P., Bores G.M., Petko W., Li M., Selk D.E., Rush D.K., Camacho F., Winslow J.T., Fishkin R., Cunningham D.M., Brooks K.M., Roehr J., Hartman H.B., Davis L., Vargas H.M. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. J. Pharmacol. Exp. Ther. 280:1997;710-720.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.280
, pp. 710-720
-
-
Smith, C.P.1
Bores, G.M.2
Petko, W.3
Li, M.4
Selk, D.E.5
Rush, D.K.6
Camacho, F.7
Winslow, J.T.8
Fishkin, R.9
Cunningham, D.M.10
Brooks, K.M.11
Roehr, J.12
Hartman, H.B.13
Davis, L.14
Vargas, H.M.15
-
4
-
-
0031637354
-
Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: Kinetic characterization
-
Al-Jafari A.A., Kamal M.A., Alhomida A.S. Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: Kinetic characterization. J. Biochem. Mol. Toxicol. 12:1998;245-251.
-
(1998)
J. Biochem. Mol. Toxicol.
, vol.12
, pp. 245-251
-
-
Al-Jafari, A.A.1
Kamal, M.A.2
Alhomida, A.S.3
-
5
-
-
0030474519
-
Inhibition of acetylcholinesterase by the Neurotoxicant, 1-Methyl-4-phenyl-2,3-dihydropyridinium ion
-
Lun-Yi Z., Misra H.P. Inhibition of acetylcholinesterase by the Neurotoxicant, 1-Methyl-4-phenyl-2,3-dihydropyridinium ion. Arch. Biochem. Biophys. 336:1996;147-150.
-
(1996)
Arch. Biochem. Biophys.
, vol.336
, pp. 147-150
-
-
Lun-Yi, Z.1
Misra, H.P.2
-
6
-
-
0028897848
-
The mode of inhibition of human erythrocyte membrane-bound acetylcholinesterase by cisplatin in vitro
-
Al-Jafari A.A., Kamal M.A., Duhaiman A.S. The mode of inhibition of human erythrocyte membrane-bound acetylcholinesterase by cisplatin in vitro. J. Enzyme Inhibit. 8:1995;281-289.
-
(1995)
J. Enzyme Inhibit.
, vol.8
, pp. 281-289
-
-
Al-Jafari, A.A.1
Kamal, M.A.2
Duhaiman, A.S.3
-
7
-
-
0013475599
-
50 with time for the inhibition of human erythrocyte acetylcholinesterase by cisplatin
-
50 with time for the inhibition of human erythrocyte acetylcholinesterase by cisplatin. Cell. Pharm. 3:1996;45-48.
-
(1996)
Cell. Pharm.
, vol.3
, pp. 45-48
-
-
Kamal, M.A.1
Al-Jafari, A.A.2
-
8
-
-
0030485545
-
Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase
-
Karnal M.A. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase. Anticancer Res. 16:1996;3725-3730.
-
(1996)
Anticancer Res.
, vol.16
, pp. 3725-3730
-
-
Karnal, M.A.1
-
9
-
-
0026606698
-
Effect of cisplatin on the activities of enzyme; Which protect against lipid peroxidation
-
Sadzuka Y., Shoji T., Takino Y. Effect of cisplatin on the activities of enzyme; which protect against lipid peroxidation. Biochem. Pharmacol. 43:1992;1872-1875.
-
(1992)
Biochem. Pharmacol.
, vol.43
, pp. 1872-1875
-
-
Sadzuka, Y.1
Shoji, T.2
Takino, Y.3
-
10
-
-
84941408701
-
3)2 (N-Py)Cl]4 binding to fumarase
-
3)2 (N-Py)Cl]4 binding to fumarase. Drug Metabol. Drug Interact. 12:1995;105-115.
-
(1995)
Drug Metabol. Drug Interact.
, vol.12
, pp. 105-115
-
-
Yalcin, G.1
-
11
-
-
0031283136
-
IC for the inhibition of human erythrocyte acetylcholinesterase by cisdiamminediaquaplatinum (II)
-
IC for the inhibition of human erythrocyte acetylcholinesterase by cisdiamminediaquaplatinum (II). Anticancer Res. 17(6):1997;4483-4486.
-
(1997)
Anticancer Res.
, vol.176
, pp. 4483-4486
-
-
Kamal, M.A.1
Bakkar, M.S.2
Al-Jafari, A.A.3
-
12
-
-
0031418951
-
Kinetics of human erythrocyte acetylcholinesterase inhibition by cisdiamminediaquaplatinum (II)
-
Kamal M.A. Kinetics of human erythrocyte acetylcholinesterase inhibition by cisdiamminediaquaplatinum (II). Anticancer Res. 17:1997;4487-4492.
-
(1997)
Anticancer Res.
, vol.17
, pp. 4487-4492
-
-
Kamal, M.A.1
-
13
-
-
0030013456
-
Investigation of the effect of antineoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase
-
Kamal M.A., Nasim F.H., Al-Jafari A.A. Investigation of the effect of antineoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase. Biochem. Mol. Biol. Int. 39:1996;293-302.
-
(1996)
Biochem. Mol. Biol. Int.
, vol.39
, pp. 293-302
-
-
Kamal, M.A.1
Nasim, F.H.2
Al-Jafari, A.A.3
-
14
-
-
0032486350
-
Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin
-
in press
-
Al-Jafari A.A., Al-Khwyter F., Kamal M.A. Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin. Cancer. Lett. 1998;. in press.
-
(1998)
Cancer. Lett.
-
-
Al-Jafari, A.A.1
Al-Khwyter, F.2
Kamal, M.A.3
-
15
-
-
0023141851
-
Kinetic investigation of the DNA platination reaction: Evidence for a transient adduct between deoxyribonucleic acid and cis-platinum (II)
-
Schaller W., Reisner H., Holler E. Kinetic investigation of the DNA platination reaction: evidence for a transient adduct between deoxyribonucleic acid and cis-platinum (II). Biochemistry. 26:1987;943-950.
-
(1987)
Biochemistry
, vol.26
, pp. 943-950
-
-
Schaller, W.1
Reisner, H.2
Holler, E.3
-
16
-
-
0030134186
-
The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase
-
Karnal M.A., Al-Jafari A.A. The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase. Prep. Biochem. Biotech. 26:1996;105-119.
-
(1996)
Prep. Biochem. Biotech.
, vol.26
, pp. 105-119
-
-
Karnal, M.A.1
Al-Jafari, A.A.2
-
18
-
-
0029738557
-
Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase
-
Al-Jafari A.A., Kamal M.A. Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase. Biochem. Mol. Biol. Int. 38:1996;577-596.
-
(1996)
Biochem. Mol. Biol. Int.
, vol.38
, pp. 577-596
-
-
Al-Jafari, A.A.1
Kamal, M.A.2
-
20
-
-
0028057738
-
The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase
-
Al-Jafari A.A., Kamal M.A. The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase. Cell. Biochem. Funct. 12:1994;29-35.
-
(1994)
Cell. Biochem. Funct.
, vol.12
, pp. 29-35
-
-
Al-Jafari, A.A.1
Kamal, M.A.2
-
22
-
-
0029902311
-
The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine
-
Al-Jafari A.A. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine. J. Ocular Pharmacol. 12:1996;503-514.
-
(1996)
J. Ocular Pharmacol.
, vol.12
, pp. 503-514
-
-
Al-Jafari, A.A.1
|